drugset / Trial / NCT00882024
Safety and Efficacy Study of Tranilast in Patients With Active Rheumatoid Arthritis (RA)
RandomizedParallel-groupQuadruple-blindTreatment
Summary
The purpose of this study is to evaluate whether tranilast at two different dosages compared to placebo is effective in patients with active RA when added to continuing methotrexate (MTX) therapy.
Timeline
- Start
- 2009-03
- Primary completion
- 2010-12
- Completion
- 2010-12
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Tranilast | Small molecule | 75 mg | — |
| Subject | Tranilast | Small molecule | 150 mg | — |